Solowin Holdings filed a Form 6-K on November 5, 2026, disclosing that it entered into a securities purchase agreement on that date to sell 1,000,000 Class B ordinary shares to Gemini Asia Holdings Limited, an entity ultimately beneficially owned by the company's Chairman and …
Invesco CurrencyShares Swiss Franc Trust filed its quarterly report on Form 10-Q with the SEC on November 6, 2026, covering the period ended September 30, 2026, and reporting total assets of $374,628,810 held primarily as interest-bearing Swiss Franc deposits.
Allogene Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 6, 2026, disclosing a net loss of $50.369 million for the three months ended September 30, 2026.
Solowin Holdings filed a Form 6-K with the SEC on November 5, 2026, disclosing a registered direct offering of 10,300,000 Class A ordinary shares at $1.20 per share to certain individual investors, with expected gross proceeds of approximately $12,360,000.
QIAGEN N.V. filed a Form 6-K with the SEC on November 5, 2026, furnishing a press release that announced unaudited financial results for the third quarter ended September 30, 2026.
Invesco CurrencyShares Euro Trust filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing financial condition and results of operations for the three and nine months ended on that date.
10x Genomics, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 6, 2026, reporting condensed consolidated balance sheet figures and share counts as of that date.
Gran Tierra Energy Inc. filed a Form 8-K on November 6, 2026, reporting that on November 5, 2026, it issued a press release announcing its financial and operating results for the quarter ended September 30, 2026.
Pershing Square Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 6, 2026, disclosing 400,000,000 shares of common stock outstanding as of October 30, 2026.
Avnet, Inc. filed its Form 10-Q for the first fiscal quarter ended October 3, 2026, with the SEC on November 6, 2026, reporting quarterly sales of $10,717,980 thousand and net income of $282,172 thousand.